Nathan Weinstein
Stock Analyst at Aegis Capital
(0.23)
# 3,248
Out of 4,479 analysts
55
Total ratings
15%
Success rate
-23.19%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $10 → $8 | $0.64 | +1,141.27% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $1.17 | +1,182.05% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.62 | +869.31% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.12 | +3,025.00% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.77 | +238.98% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.56 | +1,071.88% | 4 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $2.89 | +246.02% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $15.39 | +218.39% | 2 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.58 | +1,614.09% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $180 | $0.34 | +53,631.34% | 1 | Jan 11, 2022 | |
| CMMB Chemomab Therapeutics | Initiates: Buy | n/a | $0.97 | - | 1 | Dec 7, 2021 | |
| AVGR Avinger | Maintains: Buy | n/a | $1.69 | - | 2 | Nov 15, 2021 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | n/a | $1.22 | - | 2 | Nov 1, 2021 | |
| KTRA Kintara Therapeutics | Maintains: Buy | n/a | $0.30 | - | 3 | Sep 30, 2021 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $180 → $160 | $12.04 | +1,228.90% | 2 | Sep 22, 2021 | |
| XOMA XOMA Corporation | Maintains: Buy | n/a | $24.90 | - | 2 | Sep 9, 2021 | |
| ATAI Atai Life Sciences | Maintains: Buy | n/a | $1.35 | - | 3 | Aug 17, 2021 | |
| SCYX SCYNEXIS | Maintains: Buy | n/a | $1.95 | - | 2 | Jun 7, 2021 | |
| ENTX Entera Bio | Initiates: Buy | n/a | $1.76 | - | 1 | Mar 22, 2021 | |
| CWBR CohBar | Initiates: Buy | n/a | $0.51 | - | 1 | Mar 15, 2021 | |
| GLSI Greenwich LifeSciences | Initiates: Buy | n/a | $16.77 | - | 1 | Jan 26, 2021 | |
| VTGN VistaGen Therapeutics | Initiates: Buy | n/a | $3.57 | - | 1 | Oct 8, 2020 | |
| DYNT Dynatronics | Maintains: Buy | n/a | $0.22 | - | 1 | Sep 29, 2020 | |
| ACST Acasti Pharma | Downgrades: Hold | n/a | $2.92 | - | 2 | Sep 2, 2020 | |
| BMRA Biomerica | Initiates: Buy | n/a | $0.44 | - | 1 | Aug 21, 2020 | |
| ICCC ImmuCell | Initiates: Buy | n/a | $4.46 | - | 1 | Jul 13, 2020 | |
| AMRN Amarin Corporation | Maintains: Buy | n/a | $0.69 | - | 1 | May 4, 2020 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | n/a | $1.04 | - | 1 | Apr 13, 2020 | |
| ANIX Anixa Biosciences | Initiates: Buy | n/a | $2.22 | - | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $10 → $8
Current: $0.64
Upside: +1,141.27%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $1.17
Upside: +1,182.05%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.62
Upside: +869.31%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.12
Upside: +3,025.00%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.77
Upside: +238.98%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.56
Upside: +1,071.88%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $2.89
Upside: +246.02%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $15.39
Upside: +218.39%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.58
Upside: +1,614.09%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $180
Current: $0.34
Upside: +53,631.34%
Chemomab Therapeutics
Dec 7, 2021
Initiates: Buy
Price Target: n/a
Current: $0.97
Upside: -
Avinger
Nov 15, 2021
Maintains: Buy
Price Target: n/a
Current: $1.69
Upside: -
Inspira Technologies Oxy B.H.N.
Nov 1, 2021
Maintains: Buy
Price Target: n/a
Current: $1.22
Upside: -
Kintara Therapeutics
Sep 30, 2021
Maintains: Buy
Price Target: n/a
Current: $0.30
Upside: -
Cidara Therapeutics
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $12.04
Upside: +1,228.90%
XOMA Corporation
Sep 9, 2021
Maintains: Buy
Price Target: n/a
Current: $24.90
Upside: -
Atai Life Sciences
Aug 17, 2021
Maintains: Buy
Price Target: n/a
Current: $1.35
Upside: -
SCYNEXIS
Jun 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.95
Upside: -
Entera Bio
Mar 22, 2021
Initiates: Buy
Price Target: n/a
Current: $1.76
Upside: -
CohBar
Mar 15, 2021
Initiates: Buy
Price Target: n/a
Current: $0.51
Upside: -
Greenwich LifeSciences
Jan 26, 2021
Initiates: Buy
Price Target: n/a
Current: $16.77
Upside: -
VistaGen Therapeutics
Oct 8, 2020
Initiates: Buy
Price Target: n/a
Current: $3.57
Upside: -
Dynatronics
Sep 29, 2020
Maintains: Buy
Price Target: n/a
Current: $0.22
Upside: -
Acasti Pharma
Sep 2, 2020
Downgrades: Hold
Price Target: n/a
Current: $2.92
Upside: -
Biomerica
Aug 21, 2020
Initiates: Buy
Price Target: n/a
Current: $0.44
Upside: -
ImmuCell
Jul 13, 2020
Initiates: Buy
Price Target: n/a
Current: $4.46
Upside: -
Amarin Corporation
May 4, 2020
Maintains: Buy
Price Target: n/a
Current: $0.69
Upside: -
Ekso Bionics Holdings
Apr 13, 2020
Maintains: Buy
Price Target: n/a
Current: $1.04
Upside: -
Anixa Biosciences
Mar 23, 2020
Initiates: Buy
Price Target: n/a
Current: $2.22
Upside: -